Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting | Nachricht

IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ –Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020.

The scheduled times (noted in local Eastern Standard Time) of the presentations, titles and authors are as follows.

Oral presentations include:

  • Patient Satisfaction Following Chin Augmentation With Hyaluronic Acid Fillers: A Pooled Analysis
  • Authors: Joely Kaufman, Patricia Ogilvie, Kenneth Beer, Alexander Rivkin, Sarah Baradaran, Andrew Schumacher
  • Presenter: Joely Kaufman, MD
  • Saturday, October 10th, 11:27 a.m.
  • Treatment of Upper Facial Lines With OnabotulinumtoxinA Results in Long-Lasting Efficacy and Patient Satisfaction
    • Authors: Joel L. Cohen, Koenraad De Boulle, Steven Fagien, Jean Carruthers, Sue Ellen Cox, Patricia Ogilvie, Julie Garcia, Sara Sangha
    • Presenter: Joel L. Cohen, MD
    • Sunday, October 11
    Read More

    Securus Technologies Supports the American Cancer Society through the Company’s eCard Program during October for Breast Cancer Awareness Month | Nachricht

    DALLAS, Oct. 5, 2020 /PRNewswire/ –Securus Technologies is proud to announce the company will be donating fifty percent of proceeds from the company’s “Fight Against Breast Cancer” suite of eCards to the American Cancer Society (ACS) to help in the fight against a disease that takes thousands of lives each year.  According to, breast cancer death rates in the U.S. are higher than those for women than any other cancer, besides lung cancer.  Donating financial support to the ACS will help to fund and conduct cancer research, support patients and spread the word about prevention.

    (PRNewsfoto/Securus Technologies)

    The cost to attach an eCard to an email is one Stamp, and the proceeds from all the Stamps used in the month of October for the “Fight Against Breast Cancer” eCard category will be donated to the ACS.  Incarcerated individuals along with their loved ones in almost 40 states can purchase and

    Read More

    Soliton to Present Poster on Pivotal Cellulite Data at Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting | Nachricht

    HOUSTON, Oct. 5, 2020 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced the Company has been accepted to present its pivotal cellulite data via an online poster during the Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting, taking place October 9-11, 2020.

    Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from MD Anderson. The Company’s first planned commercial product is designed to use rapid pulses of designed acoustic shockwaves in conjunction with existing lasers to accelerate the removal of unwanted tattoos (RAP device). In addition, higher energy versions of acoustic pulse devices are in early stages of development for potential stand-alone treatment of cellulite and other indications. (PRNewsfoto/Soliton, Inc.)

    The poster presentation titled, “Improvement in the Appearance of Cellulite Depressions and Skin Laxity Resulting from a Single Treatment with Acoustic Subcision: Findings from a Multi-Center Pivotal Trial”, will be available to registered attendees beginning October 9, 2020 at 8:00 a.m. ET.

    Join our more than 200K subscribers here to follow the Company:

    About Soliton, Inc.

    Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. The

    Read More